Company Overview - Avidity Biosciences is currently experiencing a significant period of growth, particularly in the execution of three muscle disease programs [2]. Leadership - The company is led by a strong executive team, including Sarah Boyce as President and CEO, Steve Hughes as Chief Medical Officer, and Kat Lange as Chief Business Officer [1].